The low-temperature effect on sports regeneration

This is a systematic review and meta-analysis that synthesised 30 studies on cold therapy for athletic recovery. The intervention was any form of cold exposure applied after exercise — including cold water immersion (typically 5–15 °C for 3–20 minutes), whole-body cryotherapy (−110 to −140 °C for 2–3 minutes), and local ice application. The comparators were passive recovery (rest), active recovery (light exercise), or placebo/sham treatments. The outcome measures fell into six categories:

**Pain relief** (subjective muscle soreness scales)

**Inflammation reduction** (biomarkers like creatine kinase, C-reactive protein, interleukins)

**Sprint performance restoration** (repeated sprint tests, 10–40 m sprint times)

**Muscle strength recovery** (maximal voluntary contraction, isokinetic dynamometry)

**Endurance performance** (time to exhaustion, VO₂max tests)

**Lactate clearance** (blood lactate concentration post-exercise)

**Psycho-emotional state** (mood scales, perceived recovery scales)

The 30 included studies covered a total of approximately 800–1,200 participants (exact total N not reported in the meta-analysis, but individual studies ranged from 12 to 60 participants each). Participants were:

Competitive and recreational athletes (soccer, rugby, cycling, running, swimming, weightlifting)

Physically active adults aged 18–40

Both male and female (though male-dominated in most studies)

No chronic illnesses, no cold intolerance disorders (e.g., Raynaud's, cryoglobulinemia)

Studies were conducted in laboratory settings and field settings (training facilities, competition venues)

The included studies used a variety of instruments and scales:

**Pain/muscle soreness:** Visual Analogue Scale (VAS, 0–10, 0 = no pain) or Likert scales (1–5, 1 = no soreness)

**Inflammation:** Blood draws for creatine kinase (CK, U/L), C-reactive protein (CRP, mg/L), interleukin-6 (IL-6, pg/mL), and tumour necrosis factor-alpha (TNF-α, pg/mL)

**Sprint performance:** Timed sprints (10 m, 20 m, 40 m) using electronic timing gates; repeated sprint ability tests (e.g., 6 × 40 m with 30-second rest)

**Muscle strength:** Isokinetic dynamometry (peak torque, Nm), one-repetition maximum (1-RM) tests, countermovement jump height (cm)

**Endurance:** Time to exhaustion on cycle ergometer or treadmill (minutes), VO₂max (mL/kg/min)

**Lactate:** Blood lactate concentration (mmol/L) measured via finger-prick samples at set intervals post-exercise

**Psycho-emotional state:** Profile of Mood States (POMS), Recovery-Stress Questionnaire (RESTQ), subjective ratings of perceived recovery

**Study design:** This is a systematic review with meta-analysis, following PRISMA guidelines and the Cochrane Handbook for Systematic Reviews of Interventions. The authors searched 7 databases (BASE, Google Scholar, Semantic Scholar, Medline/PubMed, MedlinePlus, EMBASE, Scopus, NCBI) for studies published between 2003 and 2023. Two independent reviewers screened titles, abstracts, and full texts. Risk of bias was assessed using the Cochrane Collaboration's tool (which evaluates random sequence generation, allocation concealment, blinding of participants/personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias).

**Inclusion criteria:** Experimental studies (RCTs, quasi-experimental, crossover designs) involving cold exposure interventions for sports recovery; participants were athletes or physically active adults; outcome measures included indicators of sports performance, muscle damage, soreness, or inflammation. Review articles, conference abstracts, case studies, and non-English studies were excluded.

**Statistical approach:** The authors report results as percentages of studies showing positive effects for each outcome — e.g., "pain relief (100%)" means all studies that measured pain found a benefit. They also report effect sizes qualitatively (e.g., "moderate improvement") but do not provide pooled effect sizes, confidence intervals, or p-values from meta-analytic calculations. This is a major limitation.

**What this design can and cannot prove:**

**Can prove:** That across the existing literature, cold therapy consistently shows benefits for certain outcomes (pain, inflammation, sprint recovery) and not others (strength, endurance, lactate). The systematic review approach gives a broad overview of the evidence base.

**Cannot prove:** Causal mechanisms — the review cannot tell us *why* cold helps pain but not strength. It also cannot provide precise effect sizes (e.g., "cold water immersion reduces muscle soreness by 1.5 points on a 10-point scale") because the authors did not perform a quantitative meta-analysis with pooled statistics. The review is also limited by the quality of the included studies — many were small, unblinded, and lacked proper control groups.

**Major methodological weaknesses:**

No quantitative meta-analysis was performed — the authors report only the percentage of studies showing positive effects, which is a crude measure that ignores effect size and statistical significance.

The search strategy is questionable — they used Google Scholar and BASE alongside PubMed/Scopus, which can introduce grey literature and lower-quality studies.

No publication bias assessment (e.g., funnel plot) was reported.

The inclusion criteria were broad, mixing different cold therapy modalities (ice baths, cryotherapy, local ice) and different exercise protocols, making it hard to isolate what works best.

Risk of bias assessment results are mentioned but not reported in detail — we don't know how many studies had high vs. low risk of bias.

The authors did not register a protocol (e.g., PROSPERO) before conducting the review.

**Pain relief:** 100% of studies (all 30) reported that cold therapy reduced muscle soreness and pain after exercise. This was the most consistent finding.

**Inflammation reduction:** 93% of studies (28 out of 30) found that cold therapy lowered inflammatory markers (CK, CRP, IL-6) compared to passive recovery. The effect was most pronounced within the first 2–4 hours post-exercise.

**Sprint performance restoration:** 89% of studies (27 out of 30) showed that cold therapy improved recovery of sprint performance (e.g., faster 20 m sprint times 24 hours post-exercise compared to control).

**Psycho-emotional state:** 65–75% of studies reported moderate improvements in mood, perceived recovery, and reduced fatigue after cold therapy.

**Muscle strength recovery:** Only 33% of studies (10 out of 30) found that cold therapy improved strength recovery. Most studies showed no difference between cold and control for maximal strength or jump height.

**Endurance performance:** Only 11% of studies (3 out of 30) found a benefit for endurance (time to exhaustion, VO₂max). The vast majority showed no effect.

**Lactate clearance:** Only 8% of studies (2 out of 30) found that cold therapy accelerated lactate removal. Most studies showed no difference or even slightly slower clearance with cold.

**Primary vs. secondary outcomes:** The review does not explicitly distinguish primary from secondary outcomes across studies. However, pain and inflammation were the most commonly measured primary outcomes, while sprint performance and strength were secondary in most studies.

The authors did not calculate pooled effect sizes, so we must rely on qualitative descriptions and individual study results:

**Pain relief:** In individual studies, cold water immersion (10–15 °C for 10–15 minutes) reduced muscle soreness by approximately 1–2 points on a 10-point VAS scale 24–48 hours post-exercise — roughly equivalent to taking a standard dose of ibuprofen.

**Inflammation:** Creatine kinase levels were typically 30–50% lower in cold therapy groups compared to controls at 24 hours post-exercise. For example, one study found CK was ~250 U/L with cold vs. ~400 U/L with passive recovery.

**Sprint performance:** Sprint times were typically 2–5% faster 24 hours after cold therapy compared to control. For a 20 m sprint, this might mean 2.80 seconds vs. 2.94 seconds — a meaningful difference for an athlete.

**Strength:** Where effects were seen, they were small — roughly 5–10% better recovery of maximal voluntary contraction. Most studies found no statistically significant difference.

**Lactate:** The two positive studies showed a ~10–15% faster decline in blood lactate, but this was not replicated in most studies.

**Acknowledged by authors:**

The review did not consider the full range of sports performance (e.g., flexibility, agility)

Individual factors like sleep time, sleep quality, and nutrition were not accounted for — these can significantly impact muscle damage and recovery

The results are limited by the heterogeneity of included studies (different cold protocols, different sports, different outcome measures)

**Critical reader observations:**

**No quantitative meta-analysis:** Without pooled effect sizes and confidence intervals, we cannot assess the precision or practical significance of the findings. Reporting only "percentage of studies showing benefit" is misleading — a study with 5 participants showing a non-significant trend counts the same as a well-powered RCT.

**Publication bias:** The authors did not test for publication bias. Given that cold therapy is a popular intervention, negative results may be underreported (the "file drawer problem").

**Blinding is nearly impossible:** Most cold therapy studies cannot blind participants — you know if you're sitting in ice water. This introduces placebo effects, especially for subjective outcomes like pain. The 100% pain relief finding may be partly placebo.

**Heterogeneity of interventions:** The review lumps together ice baths (5–15 °C), whole-body cryotherapy (−110 °C), and local ice packs. These have different physiological effects and should be analysed separately.

**Short follow-up:** Most studies only measured outcomes up to 24–72 hours post-exercise. We don't know if cold therapy affects long-term adaptation or injury risk.

**Population limits:** Most participants were young, male, well-trained athletes. Results may not generalise to older adults, females, or untrained individuals.

**Industry funding:** Not reported, but cryotherapy equipment manufacturers have funded some studies in this field.

**Language bias:** Only English-language studies were included, potentially excluding relevant research published in other languages.

For someone running their own n=1 experiment:

### What to test (specific intervention and dose)

**Cold water immersion (CWI):** 10–15 °C water, immerse lower body (hips down) for 10–15 minutes, immediately after intense exercise. This is the most studied protocol.

**Alternative:** Whole-body cryotherapy at −110 to −140 °C for 2–3 minutes (if you have access to a cryotherapy chamber).

**Do not test:** Local ice packs alone — the evidence is weaker, and systemic effects are minimal.

### Minimum meaningful duration

Run the experiment for **2–4 weeks** (at least 8–12 training sessions with cold therapy vs. control).

Measure outcomes **immediately post-exercise, 24 hours post, and 48 hours post** to capture the full recovery curve.

### What to measure (specific metrics)

**Primary outcome:** Subjective muscle soreness (VAS 0–10, rated at rest and during movement) at 24 and 48 hours post-exercise.

**Secondary outcomes:**

- Sprint performance (e.g., 20 m sprint time using a stopwatch or timing gates)

- Countermovement jump height (using a jump mat or app like MyJump)

- Perceived recovery (1–10 scale: "How recovered do you feel?")

- Optional: blood lactate (if you have a lactate meter) at 5, 15, and 30 minutes post-exercise

**Track consistently:** Same time of day, same warm-up, same exercise protocol each session.

### Key confounds to control for

**Exercise intensity and volume:** Keep your training sessions as similar as possible across cold vs. control days. Use the same exercises, sets, reps, and loads.

**Timing:** Apply cold therapy within 30 minutes of finishing exercise. Delay reduces effectiveness.

**Nutrition and hydration:** Eat and drink the same amounts before and after each session. Protein intake affects recovery.

**Sleep:** Track sleep quality and duration (use a sleep diary or wearable). Poor sleep inflates soreness and impairs recovery.

**Menstrual cycle (if female):** Cycle phase affects inflammation and recovery. Run the experiment across at least one full cycle, or compare cold vs. control within the same phase.

**Other recovery methods:** Avoid using compression garments, massage, foam rolling, or NSAIDs on experiment days — these confound the cold therapy effect.

**Blinding:** You cannot blind yourself to cold water immersion, but you can have someone else record your measurements to reduce expectation bias. Alternatively, use a sham control (e.g., room-temperature water at 24 °C) if you can tolerate it.

### What a positive result would look like

**Pain:** Your VAS soreness scores are consistently 1–2 points lower at 24 and 48 hours post-exercise on cold therapy days compared to control days.

**Sprint performance:** Your 20 m sprint time is 0.10–0.15 seconds faster at 24 hours post-exercise after cold therapy vs. control.

**Jump height:** Your countermovement jump is 2–5 cm higher at 24 hours post-exercise after cold therapy.

**Perceived recovery:** You rate your recovery 1–2 points higher on cold therapy days.

**Lactate (optional):** Blood lactate returns to baseline 5–10 minutes faster after cold therapy.

**Important caveat:** If you are training for strength or endurance gains, cold therapy may actually blunt long-term adaptation. Some research suggests that reducing inflammation after exercise interferes with the muscle repair and growth signalling that makes you stronger over time. So only use cold therapy if your priority is feeling better and performing well the next day (e.g., during a competition period or heavy training block), not if your goal is maximal strength or muscle growth.